ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO
- Country
- Italy
- Type
- Beneficiary
- Website
- www.inmi.it
- Grants received
- 28
Funding record
- 28 grants on record
- €6,931,556.15 awarded in total
- 2008–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
17 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Department of Health
- UNIVERSITE D'AIX MARSEILLE
- BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
- FOLKHALSOMYNDIGHETEN
- INSTITUT PASTEUR
- ACADEMISCH ZIEKENHUIS LEIDEN
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Calls from this organisation
No published calls from this organisation.
Grants received
- European Viral Outbreak Response Alliance
- Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity
- Integrated Services for Infectious Disease Outbreak Research
- Beyond COVID
- PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION - A RANDOMISED CONTROLLED PHASE II TRIAL
- Evaluation of a production ready portable, Point-of-Need Platform (instrument and reagents), direct from nasal swab test for the molecular diagnostic detection of COVID-19 infection.
- A minituarized disposable molecular diagnostics platform for combatting coronavirus infections
- EXaSCale smArt pLatform Against paThogEns for Corona Virus
- Combating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillance
- European Clinical Research Alliance on Infectious Diseases (ECRAID) - Business Plan
- Advancing European Research Infrastcuture on Highly Pathogenic Agents
- Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics
- Point-of-Care implementation of TB testing with ultra-fast Local Heating PCR
- Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections
- PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.